VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease
ORIGINAL ARTICLE, Business Wire, September 7, 2022 BOSTON–(BUSINESS WIRE)–VoxNeuro Inc. (“VoxNeuro” or the “Company”), a commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University (“BU”), a world-class…